(Q28192701)

2

0 references

N J Talley

3

0 references

A B R Thomson

4

0 references

R Daneshjoo

5

0 references

B Eriksson

6

0 references

S Appelman-Eszczuk

7

0 references

G Långström

8

0 references

J Naesdal

9

0 references

P Serrano

10

0 references

M Singh

11

0 references

M M Skelly

12

0 references

C J Hawkey

Alimentary Pharmacology & Therapeutics

13

0 references

language of work or name

English

0 references

publication date

1 November 2005

0 references

published in

0 references

volume

22

0 references

issue

9

0 references

page(s)

795-801

0 references

cites work

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02649.X

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02649.X

Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02649.X

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02649.X

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02649.X

Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2005.02649.X

Aspirin as an antiplatelet drug

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Prophylactic aspirin and risk of peptic ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02649.X